1. AB0267 Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate: final study results of the phase 3, randomized placebo-controlled go-forward trial. (23rd January 2014) Authors: Keystone, E.; Genovese, M. C.; Hall, S.; Miranda, P. C.; Bae, S.-C.; Han, C.; Gathany, T.; Zhou, Y.; Xu, S.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0456 Improvement and maintenance of hemoglobin levels among rheumatoid arthritis, psoriatic arthritis & ankylosing spondylitis patients with anemia of inflammation after treatment with golimumab: 3 yr pooled analysis from golimumab rheumatology clinical program. (23rd January 2014) Authors: Furst, D.E.; Gathany, T.A.; Kay, J.; Wasko, M.C.; Keystone, E.; Kavanaugh, A.; Deodhar, A.; Murphy, F.; Han, C.; Doyle, M.K. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0460 Long-term remission with golimumab in active rheumatoid arthritis patients despite methotrexate through 2 years. (23rd January 2014) Authors: Keystone, E.; Genovese, M.; Klareskog, L.; Xu, S.; Han, C.; Hsia, E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0486 New, provisional american college of rheumatology and european league against rheumatism remission criteria: Results from 2 randomized, controlled golimumab trials in patients with rheumatoid arthritis. (23rd January 2014) Authors: Emery, P.; Keystone, E.; Fleischmann, R.; Genovese, M.; Klareskog, L.; Xu, S.; Han, C.; Hsia, E.C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0491 Fatigue is an independent variable predicting physical function and DAS-28 remission for patients with rheumatoid arthritis treated with intravenously administered golimumab: results from phase 3, placebo controlled clinical trial. (23rd January 2014) Authors: Westhovens, R.; Weinblatt, M.E.; Han, C.; Gathany, T.; Kim, L.; Mack, M.; Lu, J.; Baker, D.; Mendelsohn, A.M.; Bingham, C.O. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0513 Safety and efficacy of golimumab, a human anti-tnf monoclonal antibody injected subcutaneously every 4 weeks, in chinese patients with active ankylosing spondylitis: one-year results of a phase 3, randomized, placebo-controlled study. (23rd January 2014) Authors: Bao, C.; Huang, F.; Khan, M. A.; Fei, K.; Wu, Z.; Zhuang, Y.; Gathany, T.; Han, C.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Delay based noise cancelling sturdy MASH delta‐sigma modulator. Issue 5 (1st February 2014) Authors: Han, C.; Maghari, N. Journal: Electronics letters Issue: Volume 50:Issue 5(2014) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0178 Five-year safety and efficacy of golimumab in methotrexate-naïve patients with rheumatoid arthritis: final study results of the phase 3, randomized, placebo-controlled go-before trial. (23rd January 2014) Authors: Emery, P.; Fleischmann, R. M.; Strusberg, I.; Durez, P.; Nash, P.; Amante, E.; Churchill, M.; Park, W.; Pons-Estel, B.; Han, C.; Gathany, T.; Zhou, Y.; Xu, S.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0211 Safety and efficacy of subcutaneous golimumab in chinese patients with active rheumatoid arthritis despite mtx therapy: results from a randomized, placebo-controlled, phase 3 trial. (23rd January 2014) Authors: Li, Z.; Zhang, F.; Kay, J.; Fei, K.; Han, C.; Zhuang, Y.; Wu, Z.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0266 Health-Related Quality of Life of Patients with Rheumatoid Arthritis Achieving DAS28 Remission, Improvement in Physical Function and NO Radiographic Progression after Treatment with Intravenous Golimumab. (10th June 2014) Authors: Westhovens, R.; Weinblatt, M.E.; Han, C.; Kim, L.; Mack, M.; Lu, J.; Baker, D.; Mendelsohn, A.; Bingham, C.O. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗